Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled “Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting……
Subscribe To Our Free Newsletter |
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled “Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting……
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!